Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-312024-04-01falseNo description of principal activity11falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12520724 2024-04-01 2025-03-31 12520724 2023-04-01 2024-03-31 12520724 2025-03-31 12520724 2024-03-31 12520724 c:Director1 2024-04-01 2025-03-31 12520724 d:OfficeEquipment 2024-04-01 2025-03-31 12520724 d:OfficeEquipment 2025-03-31 12520724 d:OfficeEquipment 2024-03-31 12520724 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-31 12520724 d:CurrentFinancialInstruments 2025-03-31 12520724 d:CurrentFinancialInstruments 2024-03-31 12520724 d:Non-currentFinancialInstruments 2025-03-31 12520724 d:Non-currentFinancialInstruments 2024-03-31 12520724 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 12520724 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 12520724 d:ShareCapital 2025-03-31 12520724 d:ShareCapital 2024-03-31 12520724 d:RetainedEarningsAccumulatedLosses 2025-03-31 12520724 d:RetainedEarningsAccumulatedLosses 2024-03-31 12520724 c:FRS102 2024-04-01 2025-03-31 12520724 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 12520724 c:FullAccounts 2024-04-01 2025-03-31 12520724 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12520724 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 12520724









PAEDIATRIC NEUROPSYCHOLOGY LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
REGISTERED NUMBER: 12520724

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
3,288
3,918

  
3,288
3,918

Current assets
  

Debtors: amounts falling due after more than one year
 5 
25,200
25,000

Debtors: amounts falling due within one year
 5 
56,367
18,810

Cash at bank and in hand
 6 
137,786
128,618

  
219,353
172,428

Creditors: amounts falling due within one year
 7 
(56,213)
(36,578)

Net current assets
  
 
 
163,140
 
 
135,850

Total assets less current liabilities
  
166,428
139,768

  

Net assets
  
166,428
139,768


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
166,427
139,767

  
166,428
139,768


Page 1

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
REGISTERED NUMBER: 12520724
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
Dr Anna Hurley
Director

Date: 21 December 2025

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Paediatric Neuropsychology Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.   

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.4
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 4

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.


Employees

2025
2024
£
£

Wages and salaries
9,000
9,000

9,000
9,000


The average monthly number of employees, including directors, during the year was 1 (2024 - 1).


4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 April 2024
7,479


Additions
466



At 31 March 2025

7,945



Depreciation


At 1 April 2024
3,561


Charge for the year on owned assets
1,096



At 31 March 2025

4,657



Net book value



At 31 March 2025
3,288



At 31 March 2024
3,918


5.


Debtors

2025
2024
£
£

Due after more than one year

Other debtors
25,200
25,000

25,200
25,000

Page 5

 
PAEDIATRIC NEUROPSYCHOLOGY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.Debtors (continued)


2025
2024
£
£

Due within one year

Trade debtors
56,367
18,810

56,367
18,810



6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
137,786
128,618

137,786
128,618



7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Corporation tax
42,178
34,279

Other taxation and social security
12,425
600

Other creditors
170
259

Accruals and deferred income
1,440
1,440

56,213
36,578


 
Page 6